Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Fam Med Community Health. 2024 Jul 14;12(3):e002834. doi: 10.1136/fmch-2024-002834.
Older individuals with multimorbidity are at an elevated risk of infection and complications from COVID-19. Effectiveness of post-COVID-19 interventions or care models in reducing subsequent adverse outcomes in these individuals have rarely been examined. This study aims to examine the effectiveness of attending general outpatient within 30 days after discharge from COVID-19 on 1-year survival among older adults aged 85 years or above with multimorbidity.
Retrospective cohort study emulating a randomised target trial using electronic health records.
We used data from the Hospital Authority and the Department of Health in Hong Kong, which provided comprehensive electronic health records, COVID-19 confirmed case data, population-based vaccination records and other individual characteristics for the study.
Adults aged 85 years or above with multimorbidity who were discharged after hospitalisation for COVID-19 between January 2020 and August 2022.
Attending a general outpatient within 30 days of last COVID-19 discharge defined the exposure, compared to no outpatient visit.
Primary outcome was all-cause mortality within one year. Secondary outcomes included mortality from respiratory, cardiovascular and cancer causes.
A total of 6183 eligible COVID-19 survivors were included in the analysis. The all-cause mortality rate following COVID-19 hospitalisation was lower in the general outpatient visit group (17.1 deaths per 100 person-year) compared with non-visit group (42.8 deaths per 100 person-year). After adjustment, primary care consultations within 30 days after discharge were associated with a significantly greater 1-year survival (difference in 1-year survival: 11.2%, 95% CI 8.1% to 14.4%). We also observed significantly better survival from respiratory diseases in the general outpatient visit group (difference in 1-year survival: 6.3%, 95% CI 3.5% to 8.9%). In a sensitivity analysis for different grace period lengths, we found that the earlier participants had a general outpatient visit after COVID-19 discharge, the better the survival.
Timely primary care consultations after COVID-19 hospitalisation may improve survival following COVID-19 hospitalisation among older adults aged 85 or above with multimorbidity. Expanding primary care services and implementing follow-up mechanisms are crucial to support this vulnerable population's recovery and well-being.
患有多种合并症的老年人感染 COVID-19 并出现并发症的风险较高。针对这些人,COVID-19 后干预或护理模式在降低后续不良结局方面的有效性很少被研究。本研究旨在调查 COVID-19 出院后 30 天内到普通门诊就诊对 85 岁及以上患有多种合并症的老年人 1 年生存率的影响。
使用电子健康记录模拟随机对照试验的回顾性队列研究。
我们使用了来自香港医院管理局和卫生署的数据,这些数据提供了全面的电子健康记录、COVID-19 确诊病例数据、基于人群的疫苗接种记录和其他个体特征。
2020 年 1 月至 2022 年 8 月期间因 COVID-19 住院后出院的 85 岁及以上患有多种合并症的成年人。
COVID-19 出院后 30 天内到普通门诊就诊定义为暴露,与未就诊相比。
主要结局为 1 年内全因死亡率。次要结局包括因呼吸、心血管和癌症导致的死亡。
共有 6183 名符合条件的 COVID-19 幸存者纳入分析。与非就诊组(每 100 人年 42.8 例死亡)相比,普通门诊就诊组 COVID-19 住院后的全因死亡率较低(每 100 人年 17.1 例死亡)。调整后,出院后 30 天内的初级保健咨询与 1 年生存率显著提高相关(1 年生存率差异:11.2%,95%CI 8.1%至 14.4%)。我们还观察到普通门诊就诊组的呼吸系统疾病生存率显著提高(1 年生存率差异:6.3%,95%CI 3.5%至 8.9%)。在不同宽限期长度的敏感性分析中,我们发现 COVID-19 出院后参与者越早到普通门诊就诊,生存率越高。
COVID-19 住院后及时进行初级保健咨询可能会提高 85 岁及以上患有多种合并症的老年人 COVID-19 住院后的生存率。扩大初级保健服务并实施后续机制对于支持这一脆弱人群的康复和福祉至关重要。